Biogen Newsroom

Biogen Is Maintained at Buy by Truist Securities

Dow JonesJan 8 19:54

Biogen Analyst Ratings

BenzingaJan 8 19:45

Truist Financial Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $220

Futu NewsJan 8 10:31

RBC Capital Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $231

Futu NewsJan 7 21:35

Guggenheim Adjusts Price Target on Biogen to $190 From $245, Maintains Buy Rating

MT NewswiresJan 3 19:48

Biogen Price Target Cut to $138.00/Share From $315.00 by Piper Sandler

Dow JonesJan 3 00:27

Biogen Analyst Ratings

BenzingaJan 3 00:18

BMO Capital has lowered the Target Price and rating for Bojian.

Gelonghui FinanceDec 23, 2024 15:58

Leerink Partners Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $290

Futu NewsDec 21, 2024 02:43

BMO Capital Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $164

Futu NewsDec 21, 2024 02:43

Biogen's Challenges and Cautious Outlook: Hold Rating Amid Revenue Growth Struggles and Neurology Market Hurdles

TipRanksDec 21, 2024 02:13

Biogen Cut to Market Perform From Outperform by BMO Capital

Dow JonesDec 20, 2024 18:16

Biogen Analyst Ratings

BenzingaDec 20, 2024 18:06

BMO Capital Downgrades Biogen to Market Perform, Lowers Price Target to $164

BenzingaDec 20, 2024 18:06

Stifel Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $175

Futu NewsDec 16, 2024 19:32

Stifel Downgrades Biogen to Hold From Buy, Adjusts Price Target to $175 From $275

MT NewswiresDec 16, 2024 18:43

Biogen Analyst Ratings

BenzingaDec 10, 2024 20:41

B of A Securities Reinstates Neutral on Biogen, Announces $178 Price Target

BenzingaDec 10, 2024 20:39

Biogen Analyst Ratings

BenzingaDec 9, 2024 19:42

Jefferies Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $180

Futu NewsDec 9, 2024 19:31